NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19
The National Institutes of Health (NIH) made headlines when it reported encouraging data from a trial studying Remdesivir, the first experimental anti-viral medication developed by Gilead to treat COVID-19.
New Saliva Test for Diagnosing COVID-19 Infection Receives Emergency-Use Authorization By the Food and Drug Administration
This recent article in the New York Times discusses the growth of saliva-based tests for the diagnosis of infection with SARS-CoV-2, the virus that causes COVID-19.
